HAVCR2 and breast carcinoma: The expression of inhibitory receptors can also significantly impact cDC1 function and high expression of PD-L1, TIM-3 and cytotoxic T lymphocyte antigen 4 (CTLA-4) have been observed on cDC1s within human breast cancers [229,230].